XML 32 R29.htm IDEA: XBRL DOCUMENT
v3.20.1

Fair Value Measurements | 12 Months Ended
--- | ---
Dec. 31, 2019
Fair Value Measurements [Abstract] |
Fair Value Measurements | Note 2 1 – Fair value measurements Determination of Fair Value The Company uses fair value measurements to record fair value adjustments to certain assets and liabilities and to determine fair value disclosures. In accordance with the Fair Value Measurements and Disclosures topic of FASB ASC, the fair value of a financial instrument is the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market and in an orderly transaction Note 21 – Fair value measurements (continued) between market participants at the measurement date. Fair value is best determined based upon quoted market prices. However, in many instances, there are no quoted market prices for the Company’s various financial instruments. In cases where quoted market prices are not available, fair values are based on estimates using present value or other valuation techniques. Those techniques are significantly affected by the assumptions used, including the discount rate and estimates of future cash flows. Accordingly, the fair value estimates may not be realized in an immediate settlement of the instrument. The fair value guidance provides a consistent definition of fair value, which focuses on exit price in the principal or most advantageous market for an asset or liability in an orderly transaction (that is, not a forced liquidation or distressed sale) between market participants at the measurement date under current market conditions. If there has been a significant decrease in the volume and level of activity for the asset or liability, a change in valuation technique or the use of multiple valuation techniques may be appropriate. In such instances, determining the price at which willing market participants would transact at the measurement date under current market conditions depends on the facts and circumstances and requires the use of significant judgment. The fair value is a reasonable point within the range that is most representative of fair value under current market conditions. Fair Value Hierarchy In accordance with this guidance, the Company groups its financial assets and financial liabilities generally measured at fair value in three levels, based on the markets in which the assets and liabilities are traded and the reliability of the assumptions used to determine fair value.
| " |  | Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
| " |  | Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
| " |  | Level 3 inputs to the valuation methodology are unobservable and significant to the fair value measurement.
Securities Where quoted prices are available in an active market, securities are classified within Level 1 of the valuation hierarchy. Level 1 securities would include highly liquid government bonds, mortgage products and exchange traded equities. If quoted market prices are not available, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics, or discounted cash flow. Note 21 – Fair value measurements (continued) ﻿ Level 2 securities would include U.S. agency securities, mortgage-backed agency securities, obligations of states and political subdivisions and certain corporate, asset backed and other securities. In certain cases where there is limited activity or less transparency around inputs to the valuation, securities are classified within Level 3 of the valuation hierarchy. Currently, all of the Company’s securities are considered to be Level 2 securities. The following table summarizes the Company’s financial assets that were measured at fair value on a recurring basis during the period.
﻿ |  |  |  |  |  |  |
﻿ |  |  | Fair Value at December 31, 2019
Description | Balance as of December 31, 2019 |  | Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3)
﻿U.S. Treasuries | $1,964 |  | $ - |  | $1,964 |  | $ -
﻿U.S. agency obligations | 32,108 |  | - |  | 32,108 |  | -
﻿Mortgage-backed securities | 10,264 |  | - |  | 10,264 |  | -
﻿Municipals | 11,222 |  | - |  | 11,222 |  | -
﻿Corporates | 4,097 |  | - |  | 4,097 |  | -
﻿ |  |  |  |  |  |  |
﻿Total available-for-sale securities | $59,655 |  | $ - |  | $59,655 |  | $ -
﻿
﻿ |  |  |  |  |  |  |
﻿ |  |  | Fair Value at December 31, 2018
Description | Balance as of December 31, 2018 |  | Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3)
﻿U.S. Treasuries | $1,845 |  | $ - |  | $1,845 |  | $ -
﻿U.S. agency obligations | 23,267 |  | - |  | 23,267 |  | -
﻿Mortgage-backed securities | 11,876 |  | - |  | 11,876 |  | -
﻿Municipals | 12,009 |  | - |  | 12,009 |  | -
﻿Corporates | 3,730 |  | - |  | 3,730 |  | -
﻿ |  |  |  |  |  |  |
﻿Total available-for-sale securities | $52,727 |  | $ - |  | $52,727 |  | $ -
﻿ Note 21 – Fair value measurements (continued) Loans held for sale Loans held for sale are measured at lower of cost or fair value. Under ASC 820, market value is to represent fair value. Management obtains quotes or bids on all or part of these loans directly from the purchasing financial institutions. Premiums received or to be received on the quotes or bids are indicative of the fact that cost is lower than fair value. Because quotes and bids on loans held for sale are available in active markets, loans held for sale are considered to be Level 2. No nonrecurring fair value adjustments were recorded during the years ended December 31, 2019 and 2018. Gains and losses on the sale of loans are recorded in non-interest income on the Consolidated Statements of Income. Impaired loans ASC 820 applies to loans measured for impairment at an observable market price (if available), or at the fair value of the loan’s collateral (if the loan is collateral dependent). Fair value of the loan’s collateral, when the loan is dependent on collateral, is determined by appraisals or independent valuation which is then adjusted for the cost related to liquidation of the collateral. Loans are designated as impaired when, in the judgment of management based on current information and events, it is probable that all amounts due according to the contractual terms of the loan agreement will not be collected when due. The measurement of loss associated with impaired loans can be based on either the observable market price of the loan or the fair value of the collateral. Fair value is measured based on the value of the collateral securing the loans. Collateral may be in the form of real estate or business assets including equipment, inventory, and accounts receivable. The vast majority of the collateral is real estate. The value of real estate collateral is determined utilizing an income or market valuation approach based on an appraisal conducted by an independent, licensed appraiser outside of the Bank using observable market data The value of business equipment is based upon an outside appraisal if deemed significant, or the net book value on the applicable business’s financial statements if not considered significant using observable market data. Likewise, values for inventory and accounts receivables collateral are based on financial statement balances or aging reports. Any fair value adjustments are recorded in the period incurred as provision for loan losses on the Consolidated Statements of Income. The carrying values of all impaired loans are considered to be Level 3. Other Real Estate Owned Certain assets such as other real estate owned (OREO) are measured at fair value less cost to sell. We believe that the fair value component in its valuation follows the provisions of ASC 820. Real estate acquired through foreclosure is transferred to other real estate owned (“OREO”). The measurement of loss associated with OREO is based on the fair value of the collateral less anticipated selling costs compared to the unpaid loan balance. The value of OREO collateral is determined utilizing an income or market valuation approach based on an appraisal conducted by an independent, licensed appraiser outside of the Bank using market data. Note 21 – Fair value measurements (continued) Any fair value adjustments are recorded in the period incurred and expensed against current earnings. The carrying values of all OREO are considered to be Level 3. The following table summarizes the Company’s impaired loans and OREO measured at fair value on a nonrecurring basis during the period. ﻿
﻿ |  |  |  |  |  |  |
﻿ |  |  | Fair Value at December 31, 2019
Description | Balance as of December 31, 2019 |  | Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3)
﻿ |  |  |  |  |  |  |
﻿Impaired loans* | $1,239 |  | $ - |  | $ - |  | $1,239
﻿ |  |  |  |  |  |  |
﻿Other real estate | $2,339 |  | $ - |  | $ - |  | $2,339
﻿ *Includes loans charged down to the net realizable value of the collateral. ﻿
﻿ |  |  |  |  |  |  |
﻿ |  |  | Fair Value at December 31, 2018
Description | Balance as of December 31, 2018 |  | Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3)
﻿ |  |  |  |  |  |  |
﻿Impaired loans* | $1,587 |  | $ - |  | $ - |  | $1,587
﻿ |  |  |  |  |  |  |
﻿Other real estate | $2,430 |  | $ - |  | $ - |  | $2,430
﻿ *Includes loans charged down to the net realizable value of the collateral. The following table sets forth information regarding the quantitative inputs used to value assets classified as Level 3: Note 21 – Fair value measurements (continued)
﻿ | Quantitative information about Level 3 Fair Value Measurements for December 31, 2019 (dollars in thousands)
﻿ | Fair Value |  | Valuation Te chnique(s) | Unobservable Input | Range (Weighted Average)
﻿Impaired loans | $ 1,239 |  | Discounted appraised value | Selling cost | 0% - 10% (8%)
﻿ |  |  |  | Discount for lack of marketability and age of appraisal | 0% - 20% (6%)
﻿OREO | $ 2,339 |  | Discounted appraised value | Selling cost | 0% - 10% (6%)
﻿ |  |  |  | Discount for lack of marketability and age of appraisal | 0% - 25% (15%)
﻿
﻿ |  |  |  |  |
﻿ | Quantitative information about Level 3 Fair Value Measurements for December 31, 2018 (dollars in thousands)
﻿ | Fair Value |  | Valuation Te chnique(s) | Unobservable Input | Range (Weighted Average)
﻿Impaired loans | $ 1,587 |  | Discounted appraised value | Selling cost | 0% - 10% (8%)
﻿ |  |  |  | Discount for lack of marketability and age of appraisal | 0% - 20% (6%)
﻿OREO | $ 2,430 |  | Discounted appraised value | Selling cost | 0% - 10% (6%)
﻿ |  |  |  | Discount for lack of marketability and age of appraisal | 0% - 25% (15%)
﻿ Financial Instruments ﻿ FASB ASC 825, Financial Instruments, requires disclosure about fair value of financial instruments, including those financial assets and financial liabilities that are not required to be measured and reported at fair value on a recurring or nonrecurring basis. ASC 825 excludes certain financial instruments and all nonfinancial instruments from its disclosure requirements. Accordingly, the aggregate fair value amounts presented may not necessarily represent the underlying fair value of the Company. The carrying amounts and estimated fair values of the Company's financial instruments are presented in the following tables whether or not recognized on the Consolidated Balance Sheets at fair value. Fair values for December 31, 2019 and 2018 were estimated using an exit price notion. Note 21 – Fair value measurements (continued)
﻿ |  |  |  |  |  |  |  |  |
﻿ | Fair Value Measurements at December 31, 2019 using
﻿ |  |  | Quoted Prices |  | Significant |  |  |  |
﻿ |  |  | in Active |  | Other |  | Significant |  |
﻿ |  |  | Markets for |  | Observable |  | Unobservable |  |
﻿ | Carrying |  | Identical Assets |  | Inputs |  | Inputs |  |
Assets | Amounts |  | (Level 1) |  | (Level 2) |  | (Level 3) |  | Balance
﻿ Cash and due from banks | $30,794 |  | $30,794 |  | $ - |  | $ - |  | $30,794
﻿ Fed funds sold | 8,317 |  | 8,317 |  | - |  | - |  | 8,317
Securities |  |  |  |  |  |  |  |  |
﻿ Available-for-sale | 59,655 |  | - |  | 59,655 |  | - |  | 59,655
﻿ Held-to-maturity | 3,688 |  | - |  | 3,861 |  | - |  | 3,861
﻿ Restricted stock | 1,506 |  | - |  | 1,506 |  | - |  | 1,506
﻿ Loans, net | 573,274 |  | - |  | - |  | 569,850 |  | 569,850
﻿ Loans held for sale | 4,221 |  | - |  | 4,221 |  | - |  | 4,221
﻿ Interest receivable | 1,866 |  | - |  | 1,866 |  | - |  | 1,866
﻿ BOLI | 13,686 |  | - |  | 13,686 |  | - |  | 13,686
Liabilities |  |  |  |  |  |  |  |  |
﻿ Deposits | $649,459 |  | $ - |  | $651,479 |  | $ - |  | $651,479
﻿ Capital notes | 5,000 |  | - |  | 4,795 |  | - |  | 4,795
﻿ Interest payable | 173 |  | - |  | 173 |  | - |  | 173
﻿ |
﻿ |
﻿ | Fair Value Measurements at December 31, 2018 using
﻿ | Carrying |  |  |  |  |  |  |  |
Assets | Amounts |  | (Level 1) |  | (Level 2) |  | (Level 3) |  | Balance
﻿ Cash and due from banks | $26,725 |  | $26,725 |  | $ - |  | $ - |  | $26,725
﻿ Fed funds sold | 23,600 |  | 23,600 |  | - |  | - |  | 23,600
﻿ Securities |  |  |  |  |  |  |  |  |
﻿ Available-for-sale | 52,727 |  | - |  | 52,727 |  | - |  | 52,727
﻿ Held-to-maturity | 3,700 |  | - |  | 3,515 |  | - |  | 3,515
﻿ Restricted stock | 1,462 |  | - |  | 1,462 |  | - |  | 1,462
﻿ Loans, net | 530,016 |  | - |  | - |  | 522,782 |  | 522,782
﻿ Loans held for sale | 1,670 |  | - |  | 1,670 |  | - |  | 1,670
﻿ Interest receivable | 1,742 |  | - |  | 1,742 |  | - |  | 1,742
﻿ BOLI | 13,359 |  | - |  | 13,359 |  | - |  | 13,359
﻿Liabilities |  |  |  |  |  |  |  |  |
﻿ Deposits | $612,043 |  | $ - |  | $612,532 |  | $ - |  | $612,532
﻿ Capital notes | 5,000 |  | - |  | 4,710 |  | - |  | 4,710
﻿ I nterest payable | 127 |  | - |  | 127 |  | - |  | 127
﻿ ﻿ ﻿ ﻿

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -URI http://asc.fasb.org/topic&trid=2155941 + Details
Name: | us-gaap_FairValueMeasurementInputsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration